| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$430.00
Est. +14%
|
$378.42 | $415.76 |
Pending
|
$406.09
+7.3%
|
| Aug 20, 2026 |
Moderna Inc
MRNA
|
SELL |
$150.00
Est. +14%
|
$174.38 | $130.00 (Low) |
Target Met
|
$182.11
-4.4%
|
| Jul 23, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$90.00
Est. +46%
|
$61.84 | $72.64 |
Pending
|
$57.89
-6.4%
|
| Jun 09, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$175.00
Est. +18%
|
$148.45 | $224.31 |
Target Met
|
$190.74
+28.5%
|
| May 27, 2026 |
Pfizer Inc.
PFE
|
BUY |
$27.00
Est. +2%
|
$26.35 | $29.21 |
Target Met
|
$28.17
+6.9%
|
| Mar 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$70.00
Est. +17%
|
$59.79 | $68.24 |
Precision Hit (±3%)
|
$61.15
+2.3%
|
| Feb 24, 2026 |
Arcellx Inc
ACLX
|
BUY |
$115.00
Est. +1%
|
$113.75 | $115.13 |
Bullseye Hit (±1%)
|
$115.07
+1.2%
|
| Jan 08, 2026 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$14.00
Est. +2%
|
$13.73 | $14.07 |
Bullseye Hit (±1%)
|
$14.00
+2.0%
|
| Jan 07, 2026 |
Beam Therapeutics Inc
BEAM
|
SELL |
$28.00
Est. +1%
|
$28.34 | $21.63 (Low) |
Target Met
|
$24.37
+14.0%
|
| Jan 07, 2026 |
SAB Biotherapeutics Inc
SABS
|
BUY |
$7.00
Est. +93%
|
$3.62 | $5.15 |
Pending
|
$3.39
-6.4%
|
| Jan 07, 2026 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$55.00
Est. +67%
|
$32.85 | $37.95 |
Pending
|
$31.54
-4.0%
|
| Jan 07, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$50.00
Est. +88%
|
$26.62 | $112.95 |
Target Met
|
$89.93
+237.8%
|
| Jan 07, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$145.00
Est. +19%
|
$121.36 | $157.27 |
Target Met
|
$151.37
+24.7%
|
| Jan 07, 2026 |
Arcellx Inc
ACLX
|
BUY |
$100.00
Est. +61%
|
$62.06 | $115.13 |
Target Met
|
$115.07
+85.4%
|
| Jan 07, 2026 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$45.00
Est. +80%
|
$25.04 | $29.50 |
Pending
|
$8.83
-64.7%
|
| Jan 07, 2026 |
Denali Therapeutics Inc
DNLI
|
BUY |
$25.00
Est. +45%
|
$17.21 | $27.30 |
Target Met
|
$20.46
+18.9%
|
| Jan 07, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$70.00
Est. +59%
|
$43.91 | $72.27 |
Target Met
|
$50.77
+15.6%
|
| Jan 07, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$60.00
Est. +45%
|
$41.31 | $61.75 |
Precision Hit (±3%)
|
$49.85
+20.7%
|
| Jan 07, 2026 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +18%
|
$8.49 | $9.10 |
Pending
|
$5.71
-32.7%
|
| Jan 07, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$60.00
Est. +109%
|
$28.70 | $72.64 |
Target Met
|
$57.89
+101.7%
|
| Jan 07, 2026 |
Inventiva - ADR
IVA
|
BUY |
$12.00
Est. +164%
|
$4.54 | $7.29 |
Pending
|
$3.45
-24.0%
|
| Jan 07, 2026 |
Kodiak Sciences Inc
KOD
|
BUY |
$50.00
Est. +100%
|
$25.05 | $47.84 |
Pending
|
$31.52
+25.8%
|
| Jan 07, 2026 |
Schrodinger Inc
SDGR
|
SELL |
$18.00
Est. +4%
|
$18.79 | $10.95 (Low) |
Target Met
|
$29.23
-55.6%
|
| Jan 07, 2026 |
Cogent Biosciences Inc
COGT
|
BUY |
$60.00
Est. +73%
|
$34.78 | $43.39 |
Pending
|
$31.41
-9.7%
|
| Jan 07, 2026 |
Aligos Therapeutics Inc
ALGS
|
BUY |
$20.00
Est. +128%
|
$8.76 | $10.49 |
Pending
|
$5.45
-37.8%
|
| Jan 06, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,250.00
Est. +17%
|
$1,064.04 | $1,264.73 |
Precision Hit (±3%)
|
$1,152.70
+8.3%
|
| Jan 06, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$535.00
Est. +14%
|
$468.38 | $560.25 |
Target Met
|
$516.34
+10.2%
|